The use of artificial nutrition among cancer patients enrolled in palliative home care services

被引：21
作者：
Orrevall, Y. [1 ,2 ]
Tishelman, C. [3 ,4 ]
Permert, J.
Cederholm, T. [5 ]
机构：
[1] Stockholms Sjukhem Fdn, R&D Unit, SE-11235 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Surg, Stockholm, Sweden
[3] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden
[4] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England
[5] Uppsala Univ, Dept Publ Hlth & Caring Sci Clin Nutr & Metab, Uppsala, Sweden
来源：
PALLIATIVE MEDICINE | 2009年 / 23卷 / 06期
关键词：
enteral tube feeding; home care services; neoplasm; nutritional support palliative care; parenteral nutrition; TOTAL PARENTERAL-NUTRITION; QUALITY-OF-LIFE; ENTERAL NUTRITION; ESPEN GUIDELINES; CLINICAL-TRIALS; EXPERIENCES; MANAGEMENT; KNOWLEDGE; INTERVIEW; HYDRATION;
D O I：
10.1177/0269216309105811
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
In this study, patients' views and experiences of using home artificial nutrition, and factors associated with use of home parenteral nutrition (HPN) were investigated. Structured telephone interviews with 620 cancer patients enrolled in 21 palliative home care services were analysed. HPN was more common (11%) than home enteral tube feeding (HETF, 3%). Home artificial nutrition (including HPN and HETF) was usually introduced more than four months before death. Three of four HPN recipients also had oral food intake. HPN use was associated with eating difficulties, nausea/vomiting, and fatigue rather than gastrointestinal problems per se. HETF was generally used for patients with problems related to oesophagus and head and neck tumours. In conclusion the results suggest that, contrary to existing guidelines, HPN is used to supplement oral intake, and not only for patients with a non-functioning gastrointestinal tract. Palliative Medicine (2009); 23: 556-564
引用
收藏
页码：556 / 564
页数：9
相关论文
共 34 条
[1]  
[Anonymous], WHO Definition of Palliative Care
[2]   ESPEN guidelines on enteral nutrition:: Non-surgical oncology [J].
Arends, J. ;
Bodoky, G. ;
Bozzetti, F. ;
Fearon, K. ;
Muscaritoli, M. ;
Selga, G. ;
van Bokhorst-de van der Schuereng, M. A. E. ;
von Meyenfeldt, M. ;
Zuercher, G. ;
Fietkau, R. ;
Aulbert, E. ;
Frick, B. ;
Holm, M. ;
Kneba, M. ;
Mestrom, H. J. ;
Zander, A. .
CLINICAL NUTRITION, 2006, 25 (02) :245-259
[3]  
ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, J PARENTER ENTERAL S, V26, p1SA
[4]   Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001) [J].
Bachmann, P ;
Marti-Massoud, C ;
Blanc-Vincent, MP ;
Desport, JC ;
Colomb, V ;
Dieu, L ;
Kere, D ;
Melchior, JC ;
Nitenberg, G ;
Raynard, B ;
Roux-Bournay, P ;
Schneider, S ;
Senesse, P .
BRITISH JOURNAL OF CANCER, 2003, 89 (Suppl 1) :S107-S110
[5]   Guidelines on artificial nutrition versus hydration in terminal cancer patients [J].
Bozzetti, F .
NUTRITION, 1996, 12 (03) :163-167
[6]   Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between? [J].
Bozzetti, F .
CLINICAL NUTRITION, 2003, 22 (02) :109-111
[7]   Quality of life and length of survival in advanced cancer patients on home parenteral nutrition [J].
Bozzetti, F ;
Cozzaglio, L ;
Biganzoli, E ;
Chiavenna, G ;
De Cicco, M ;
Donati, D ;
Gilli, G ;
Percolla, S ;
Pironi, L .
CLINICAL NUTRITION, 2002, 21 (04) :281-288
[8]  
Fuhrman M Patricia, 2006, Nutr Clin Pract, V21, P134, DOI 10.1177/0115426506021002134
[9]   Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience [J].
Hoda, D ;
Jatoi, A ;
Burnes, J ;
Loprinzi, C ;
Kelly, D .
CANCER, 2005, 103 (04) :863-868
[10]   Management of complications in patients receiving home parenteral nutrition [J].
Howard, L ;
Ashley, C .
GASTROENTEROLOGY, 2003, 124 (06) :1651-1661
1234